We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+6.4%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$301B
AUM Growth
+$5.54B
Cap. Flow
-$7B
Cap. Flow %
-2.32%
Top 10 Hldgs %
14.22%
Holding
9,997
New
1,505
Increased
3,920
Reduced
3,392
Closed
881

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$937M
2
UBS icon
UBS Group
UBS
+$511M
3
MSFT icon
Microsoft
MSFT
+$402M
4
BIDU icon
Baidu
BIDU
+$338M
5
AAPL icon
Apple
AAPL
+$331M

Sector Composition

Rank Sector Weight
1 Technology 11.08%
2 Consumer Discretionary 6.75%
3 Financials 6.3%
4 Healthcare 5.83%
5 Industrials 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KPRX icon
7326
Kiora Pharmaceuticals
KPRX
$11.3M
$21K ﹤0.01%
12
+1
+9% +$2.18K
KRMD icon
7327
KORU Medical Systems
KRMD
$190M
$21K ﹤0.01%
6,036
-5,980
-50% -$25.9K
MNSB icon
7328
MainStreet Bancshares
MNSB
$168M
$21K ﹤0.01%
991
-159
-14% -$3.02K
MRM
7329
MEDIROM Healthcare Technologies
MRM
$7.06M
$21K ﹤0.01%
1,835
-566
-24% -$7.15K
SDEV
7330
Stablecoin Development Corp
SDEV
$52M
$21K ﹤0.01%
4
+2
+100% +$12.5K
NXTC icon
7331
NextCure
NXTC
$21.4M
$21K ﹤0.01%
177
-467
-73% -$67.6K
OLMA icon
7332
Olema Pharmaceuticals
OLMA
$1.01B
$21K ﹤0.01%
636
-52,617
-99% -$2.25M
OPBK icon
7333
OP Bancorp
OPBK
$235M
$21K ﹤0.01%
1,999
+510
+34% +$4.69K
OPTN
7334
DELISTED
OptiNose
OPTN
$21K ﹤0.01%
374
-199
-35% -$12.1K
RDNW
7335
RideNow Group
RDNW
$259M
$21K ﹤0.01%
+485
New +$19.4K
SANW
7336
DELISTED
S&W Seed Co
SANW
$21K ﹤0.01%
+300
New +$20.4K
SCC icon
7337
ProShares UltraShort Consumer Discretionary
SCC
$6.43M
$21K ﹤0.01%
493
+258
+110% +$11.6K
ZSL icon
7338
ProShares UltraShort Silver
ZSL
$55.2M
$21K ﹤0.01%
19
+6
+46% +$6.14K
CFCV
7339
DELISTED
ClearBridge Focus Value ESG ETF
CFCV
$21K ﹤0.01%
630
+130
+26% +$4.07K
OCAXU
7340
DELISTED
OCA Acquisition Corp. Unit
OCAXU
$21K ﹤0.01%
+2,148
New +$22.1K
ESHY
7341
DELISTED
Xtrackers J.P. Morgan ESG USD High Yield Corporate Bond ETF
ESHY
$21K ﹤0.01%
1,014
-1,037
-51% -$21.9K
PGAL
7342
DELISTED
Global X MSCI Portugal ETF
PGAL
$21K ﹤0.01%
1,935
+1,413
+271% +$15.5K
HT
7343
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$21K ﹤0.01%
2,044
-4,219
-67% -$40.7K
FLIY
7344
DELISTED
Franklin FTSE Italy ETF
FLIY
$21K ﹤0.01%
775
-177
-19% -$4.52K
ZYNE
7345
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$21K ﹤0.01%
4,503
-2,726
-38% -$12.4K
PGRWU
7346
DELISTED
Progress Acquisition Corp. Units
PGRWU
$21K ﹤0.01%
+2,173
New +$21.9K
NKG
7347
DELISTED
Nuveen Georgia Quality Municipal Income Fund
NKG
$21K ﹤0.01%
1,589
-18,162
-92% -$235K
ISDX
7348
DELISTED
Invesco Exchange-Traded Self-Indexed Fund Trust Invesco RAFI Strategic Developed ex-US ETF
ISDX
$21K ﹤0.01%
707
-1,018
-59% -$29.4K
HAACU
7349
DELISTED
Health Assurance Acquisition Corp. SAIL Securities
HAACU
$21K ﹤0.01%
+1,995
New +$24.8K
RJZ
7350
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Metals Total Return
RJZ
$21K ﹤0.01%
2,005
+859
+75% +$8.94K

Similar funds

UBS Group's Q1 2021 Portfolio in Review

As of Q1 2021, UBS Group held 9,997 positions worth $301B, up 1.9% from $296B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q1 2021 filing shows 1,505 new, 3,920 increased, 3,392 reduced and 881 closed positions. Its largest new stake was Ferguson: 1,602,252 shares worth $192M. The largest sale was Stellantis, an estimated $937M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Financials.

  • UBS Group's largest Q1 2021 buy was Ferguson: 1,602,252 shares worth $192M.
  • UBS Group added most to Alibaba in Q1 2021, an estimated $2.76B increase.
  • UBS Group's biggest Q1 2021 reduction was Stellantis, cutting an estimated $937M.
  • UBS Group fully exited Tiffany & Co. in Q1 2021, selling an estimated $77.2M.
  • UBS Group's ten largest holdings make up 14% of its $301B portfolio in Q1 2021.
  • UBS Group opened 1,505 new positions and closed 881 in Q1 2021.
  • UBS Group's portfolio value rose 1.9% quarter-over-quarter to $301B.

Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.